About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Active Not Recruiting

The Analysis of Fatigue on Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukaemia

NCT06233890•Imperial College Healthcare NHS Trust

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Chronic Myeloid LeukemiaChronic Myeloid Leukemia, Chronic PhaseFatigue+1 more

Interventions

Motion watch

Locations

1

United Kingdom

Locations (1)

Imperial NHS Healthcare Trust

London, United Kingdom

Key Dates

Start Date

May 12, 2023

Primary Completion Date

May 12, 2025

Completion Date

May 12, 2026

Last Updated

January 31, 2024

Related Studies

Virtual Patient Groups for Sarcoidosis Associated Fatigue

NCT07073963

SarcoidosisFatigue+3 more

RECRUITINGPhase 3

Methylphenidate in Pediatric Brain Tumor Survivors With Cancer-related Fatigue

NCT06905587

Brain Tumor, PediatricCancer-related Fatigue+1 more

RECRUITINGPhase 2

Open-label Study of Asciminib for CML-CP or CML-AP Patients With T315I Mutation Who Are Resistant, Intolerant or Ineligible to Ponatinib.

NCT06514534

Chronic Myeloid Leukemia (CML)

REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors

NCT06710548

Ovarian CancerAdvanced Ovarian Carcinoma+5 more

Is Post-exertional Symptom Exacerbation Specific to Patients With Myalgic Encephalomyelitis / Chronic Fatigue Syndrome? A Study Comparing Patients With Myalgic Encephalomyelitis / Chronic Fatigue Syndrome and Patients With Cardiac Diseases Who Underwent an Exercise Test.

NCT07491315

Fatigue Syndrome, ChronicCardiovascular Diseases

RECRUITINGPhase 2

Asciminib as Initial Therapy for Patients With Chronic Myeloid Leukemia in Chronic Phase

NCT05143840

Chronic Myeloid Leukemia, Chronic PhaseAdult CML+2 more

View all related studies

Sponsors

Lead Sponsor

Imperial College Healthcare NHS Trust

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 31, 2024Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions